Ten‐year experience of recombinant activated factor VII use in surgical patients with congenital haemophilia with inhibitors or acquired haemophilia in Japan-Reference-Cited by-同舟云学术

Ten‐year experience of recombinant activated factor VII use in surgical patients with congenital haemophilia with inhibitors or acquired haemophilia in Japan

Published:2014-12-18 Issue:3 Volume:21 Page:374-379
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Takedani H.¹,Shima M.²,Horikoshi Y.³,Koyama T.⁴,Fukutake K.⁵,Kuwahara M.⁶,Ishiguro N.⁷

Affiliation:

1. Hospital of the Institute of Medical Science of the University of Tokyo (IMSUT) TokyoJapan

2. Nara Medical University KashiharaJapan

3. Shizuoka Children's Hospital ShizuokaJapan

4. Tokyo Medical and Dental University TokyoJapan

5. Tokyo Medical University TokyoJapan

6. Novo Nordisk Pharma Ltd. TokyoJapan

7. Nagoya University School of Medicine Nagoya Japan

Publisher

Wiley

Subject

Genetics (clinical),Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hae.12611

Reference19 articles.

1. Inhibitor treatment in haemophilias A and B: summary statement for the 2006 international consensus conference

2. Factor VIIa and its potential therapeutic use in bleeding-associated pathologies

3. Activated factor VII activates factors IX and X on the surface of activated platelets: thoughts on the mechanism of action of high‐dose activated factor VII;Hoffman M;Blood Coagul Fibrinolysis,1998

4. European Study on Orthopaedic Status of haemophilia patients with inhibitors

5. SUCCESSFUL USE OF RECOMBINANT FACTOR VIIa IN PATIENT WITH SEVERE HAEMOPHILIA A DURING SYNOVECTOMY

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current status and future prospects of activated recombinant coagulation factor VIIa, NovoSeven®, in the treatment of haemophilia and rare bleeding disorders;Annals of Hematology;2023-06-30

2. A multicenter, observational study to evaluate hemostasis following recombinant activated FVII treatment in patients in Japan with congenital factor VII deficiency;Blood Coagulation & Fibrinolysis;2023-06-23

3. Stoma takedown after Hartmann’s procedure in a patient with hemophilia A complicated with production of inhibitor to FVIII (review and case report);Koloproktologia;2022-12-21

4. Acquired Haemophilia A: A Review of What We Know;Journal of Blood Medicine;2022-11

5. A Case Report of Acquired Hemophilia after Robot-Assisted Laparoscopic Gastrectomy for Gastric Cancer;The Japanese Journal of Gastroenterological Surgery;2022-10-01